Annie Clauss

Title: The Innovative Contributions of Annie Clauss

Introduction

Annie Clauss is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals, holding a total of four patents. Her work focuses on the development of novel compounds with therapeutic applications.

Latest Patents

Annie Clauss's latest patents include innovative compounds such as 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives. This invention relates to compounds of a specific formula, including their racemic, enantiomeric, or diastereoisomeric isomers, as well as pharmaceutically acceptable salts. Another notable patent is for 2,3-dihydro-1H-imidazo(1,2-a)pyrimidin-5-one derivatives, which encompasses a product of a defined formula, its therapeutic use, a process for its production, and a pharmaceutical composition that includes the product.

Career Highlights

Annie Clauss is currently employed at Sanofi, a leading global healthcare company. Her role involves extensive research and development in the pharmaceutical sector, where she applies her expertise to create innovative solutions for health-related challenges.

Collaborations

Annie has collaborated with notable colleagues such as Gilbert Marciniak and Bertrand Vivet. These partnerships have contributed to her success and the advancement of her research projects.

Conclusion

Annie Clauss exemplifies the spirit of innovation in the pharmaceutical industry through her patents and collaborative efforts. Her work continues to impact the field positively, showcasing the importance of research and development in healthcare.